Saturn V Capital Management LP

Position in ABVX — Abivax S.A.

CIK 1964437 AUSTIN, TX

Position in ABVX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$69,143,949

+$8,714,750 QoQ

Shares Held

518,865

-4.4% QoQ

Ownership

0.595%

of shares outstanding

% of Portfolio

9.91%

of 13F equity value

Holder Rank

#29

of 302 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Saturn V Capital Management LP holds $614,415,149 across 22 Biotechnology names. ABVX ranks #2 (11.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALMS	Alumis Inc.	2,915,443	$82,040,566
2	ABVX	Abivax S.A. This page	518,865	$69,143,949
3	PCVX	Vaxcyte, Inc.	852,914	$49,579,890
4	IMMX	Immix Biopharma, Inc.	4,658,429	$48,028,402
5	PHVS	Pharvaris N.V.	1,314,122	$45,442,338
6	JAZZ	Jazz Pharmaceuticals plc	160,938	$38,781,229
7	CELC	Celcuity Inc.	370,318	$38,742,669
8	IRON	Disc Medicine, Inc.	524,730	$38,378,752

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$69,143,949	518,865	-4.4%	Shares	Sole	2026-08-14
2026-03-31	$60,429,199	542,696	-16.4%	Shares	Sole	2026-05-15
2025-12-31	$87,545,034	649,179	-19.0%	Shares	Sole	2026-02-17
2025-09-30	$68,023,917	801,224	+28.7%	Shares	Sole	2025-11-14
2025-06-30	$4,761,964	622,479	+12.6%	Shares	Sole	2025-08-13
2025-03-31	$3,455,787	552,926	-15.3%	Shares	Sole	2025-05-15
2024-12-31	$4,780,479	653,071	+0.8%	Shares	Sole	2025-02-14
2024-09-30	$7,465,178	648,019	+3.2%	Shares	Sole	2024-11-14
2024-06-30	$8,298,987	627,760	+0.8%	Shares	Sole	2024-08-14
2024-03-31	$8,908,471	622,970	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.